[13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis

This publication has 25 references indexed in Scilit:

• Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action
  Journal of Clinical Endocrinology & Metabolism, 1992
• Quantitation of Hepatic Glycogenolysis And Gluconeogenesis in Fasting Humans With ¹³ C NMR
  Science, 1991
• Simultaneous synthesis and degradation of rat liver glycogen. An in vivo nuclear magnetic resonance spectroscopic study.
  Journal of Clinical Investigation, 1990
• Modulation by somatostatin of nerve‐mediated activation of glycogenolysis in the perfused rat liver
  FEBS Letters, 1989
• Metabolic pathways for ketone body production. Carbon-13 NMR spectroscopy of rat liver in vivo using carbon-13-multilabeled fatty acids
  Biochemistry, 1986
• EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN
  Clinical Endocrinology, 1986
• Effects of Somatostatin, Glucagon and Insulin on Glycogen Synthesis in Isolated Rat Hepatocytes
  Hormone and Metabolic Research, 1984
• Effects of somatostatin on liver glycogen and fat metabolism in vivo.
  The Japanese Journal of Pharmacology, 1984
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of Langerhans and isolated hepatocytes
  Biochemical and Biophysical Research Communications, 1975